always online......
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks fine today....CBIS.....
CBIS is trading in Germany's Stuttgart.....
Germany to allow medical cannabis consumption in some cases - The ...https://www.washingtonpost.com/...cannabis.../fb054...
- Germany's Cabinet has approved a bill that will allow patients to get cannabis as a prescription-only medication.
"I have even saved a few 1-acre parcels for our shareholders who have expressed serious interest and are waiting to hear back from me to review the schematics and the deal. Everyone will be able to review these documents at that point. 41 acres goes a long way and over 1,000 acres goes a lot further; we are going the distance regardless, just watch these next few moves," concluded Mr. Dabney
We want to move forward at light speed. I feel this will take us to the next level. We will release the first version schematics for the Nevada facilities in a couple days. There will be some VERY pleasantly surprised people out there. I think the people have spoken, with the University, medical complex, and cultivation centers in one area is a serious community builder, so many new jobs, education, medical treatments, and many more economic growth advantages is the type of forward thinking required in this burgeoning Cannabis Industry to expand properly across the Country and around the world.
-- 05/03/16 Cannabis Science CEO Sees Over 3,000 Shareholders Registering for Their Loyalty Gifts, as the Company Looks at Plans Coming Together to Unveil the Schematics of Its 360,000 sq. ft. Nevada Drug Development Complex Within the Next Few Days
COLORADO SPRINGS, CO -- (Marketwired) -- 05/03/16 -- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine, is currently processing more than 3,000 shareholder requests for their "loyalty gift" from CEO Raymond C. Dabney. This is a remarkable number to say the least, as the company draws near the release of the schematics for its 360,000 sq. ft., Nevada drug development complex later this week.
"I am simply amazed. I never imagined seeing the sheer number of shareholders expressing well wishes and success to our drug development programs. From shareholder interest in investing in the Nevada project, to just wanting to say Thank you with or without the gift is a true testament to the loyalty of the Cannabis Science investors. The number of emails I have received personally thanking me is astounding. It sure does feel good to have a small army backing you up when it's certainly been a battle in a war that rages on. At this point, I think we are becoming a major force in the conflict against critical ailments," stated Cannabis Science President & CEO, Co- Founder, Raymond C. Dabney.
"We are working our way through the documentation with my legal team, as quickly as possible to ensure our successful completion. With these overwhelming numbers coming in, we are thinking of a much simpler way to accommodate the gifts; we have some good ideas getting vetted right now. I want to see this closed out and completed by the end of this month. We have so many projects in front of us. Time to quit looking in the rear view mirror. It is time to look forward towards new developments and projects. We believe we are creating sustainable value for our shareholders," said Dabney.
"So much has changed so quickly. What is even more compelling: the company has verbally agreed to investors, associates, and/or partnerships for a number of its available parcels in the Nevada development. This level of excitement being expressed before we release the schematics tells me we are on to something big! We want to move forward at light speed. I feel this will take us to the next level. We will release the first version schematics for the Nevada facilities in a couple days. There will be some VERY pleasantly surprised people out there. I think the people have spoken, with the University, medical complex, and cultivation centers in one area is a serious community builder, so many new jobs, education, medical treatments, and many more economic growth advantages is the type of forward thinking required in this burgeoning Cannabis Industry to expand properly across the Country and around the world.
"I have even saved a few 1-acre parcels for our shareholders who have expressed serious interest and are waiting to hear back from me to review the schematics and the deal. Everyone will be able to review these documents at that point. 41 acres goes a long way and over 1,000 acres goes a lot further; we are going the distance regardless, just watch these next few moves," concluded Mr. Dabney
About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
Forward-Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company are detailed from time to time in the company's reports filed with the Securities and Exchange Commission.
Cannabis Science, Inc.
Investor Relations
Teresa Misenheimer
teresa@cannabisscience.com
Tel: 1-888-263-0832
Cannabis Science, Inc.
Mr. Raymond C. Dabney
Director, President & CEO, Co-Founder
raymond.dabney@cannabisscience.com
Tel:1-888-263-0832
Cannabis Science, Inc.
Mr. Robert Kane
Director & CFO
info@cannabisscience.com
Tel: 1-888-263-0832
Source: Cannabis Science, Inc.
Are you interested in becoming a part of our team and spreading awareness of CBD??
Collectives, Reps, and CBD Farmers wanted.
Available positions in the following areas-
* Emerald Triangle
* Bay Area / Santa Cruz
* Sacramento
* Central Valley / Visalia
* Los Angeles / Orange County
* San Diego
* Big Bear
* Everywhere in California
For inquiries please call 1.800.2FINDCBD or email orders@cbdinnovation.com
MessageSend
http://www.presidentialrx.com/#!contact/cyjs
very fine...
REDONDO BEACH, CA / ACCESSWIRE / April 27, 2016 / The cannabis industry could reach $35 billion by 2020, according to GreenWave Advisors, driven by legalization in a growing number of states. Within this so-called green rush, investors have a number of different investment opportunities. Cannabis Science Inc. (OTC: CBIS) provides investors with exposure to the research side of the business, while American Cannabis Company (OTC: AMMJ) is focused on consulting services.
The media side of the business is often neglected by investors, but could become a large part of the overall industry moving forward. MassRoots Inc. (OTC: MSRT) has already attracted more than 775,000 users and thousands of businesses looking to reach those users. Pot Network Inc. (OTC: POTN) has similarly sought to build out a leading content network focused on breaking news, research, and other topics of interest to the growing cannabis community.
In this article, we'll take a look at CrowdGather Inc. (OTCQB: CRWG) and why it could be the next big opportunity in the media niche of the burgeoning cannabis industry.
CrowdGather Focuses on Cannabis
CrowdGather Inc. (OTCQB: CRWG) recently announced the sale of its Plaor gaming subsidiary to focus its efforts on its specialty cannabis and consumer publishing network. Last year, the company acquired WeedTracker.com and various other cannabis-related domain names including WeedInHollywood.com and DispensaryWeed.com. The plan was to extend WeedTracker into a mobile locator app and build out the other domains into niche properties.
The rapid growth of its Plaor gaming business put some of those plans on hold, but recently, the company was forced to divest the business. On April 20th, the gaming division was sold for $3.5 million in a move that reduced its corporate debt by 43% and put it on more stable financial footing. The company's primary creditor also agreed to convert debt at a price of $0.01 per share in order to help it complete an upcoming equity financing at the same price.
Management announced a restructuring at the same time that involves refocusing on its cannabis properties. With hundreds of thousands of visitors to its existing forum properties, the company has a lot of experience building up online communities and monetizing them. The company also built up its Plaor gaming business to 20,000 daily active users and launched a series of new products, which demonstrates its ability to execute on its vision.
Improved Balance Sheet
CrowdGather's decision to exit the social gaming business and double-down on the cannabis industry helped significantly improve its financial condition. As a part of the transaction, the acquiring firm assumed approximately $1.8 million in debt and $500,000 in other liabilities, which reduced its total debt by around 43%. Deferred payments totaling nearly $1 million, beginning in a year, could further reduce these debt levels.
Management's efforts to restructure its debt with Iconic Holdings could also make financing a lot easier moving forward. By converting their shares at $0.01, the company's largest creditor has made it possible for the company to move forward with raising $1 million.
CEO Sanjay Sabnani also agreed to convert $240,000 in funding that he lent to the company on similar terms as part of a financing round not to exceed $1 million in aggregate. Mr. Sabnani's willingness to convert funding on these terms represents a strong vote of confidence in the company's future, especially when considered alongside his numerous net open market purchases of common stock - most recently at prices of around $0.04 per share.
CEO Sanjay Sabnani hopes to achieve a breakeven point by the end of the year, which will depend on the company's ability to cost-effectively raise capital. The reduced debt load and cost-cutting measures implemented over the past couple of years should help improve margins and bring the company closer to that goal. By focusing on a single vertical, the company hopes to apply its skills and accelerate revenue with the proper funding in place.
Looking Ahead
CrowdGather's move into the burgeoning cannabis industry marks a turning point in its corporate history. After selling off its gaming business, the company is concentrating its efforts on growing in the new vertical market and achieving a breakeven this year. Investors interested in capitalizing on the cannabis industry may want to keep an eye on the stock as the latest play in the rapidly growing media niche of the industry.
For more information, visit the company's website at www.crowdgather.com
SOURCE: Emerging Growth LLC
© Copyright © 2016 Accesswire. All rights reserved.
CORAL SPRINGS, Florida, April 20, 2016 /PRNewswire/ --
Global opportunities are promising for legalized marijuana and cannabis sector as revenues continue to thrive behind increased federal & governmental research and development of latest products. Marijuana & Cannabis Companies with current operations and developments of importance in the markets today are New Colombia Resources, Inc. (NEWC), Cannabis Science, Inc. (CBIS), Cara Therapeutics (CARA), Terra Tech Corp. (TRTC) and Cannabis Sativa Inc. (CBDS).
New Colombia Resources, Inc. (NEWC), a U.S. company with natural resource assets in Colombia, is pleased to announce that its subsidiary, Sannabis SAS, has received orders from an established pharmacy chain distributing natural products in southwest Colombia. Natural Pharmacy chain Salud Semillas, a leading distributor of natural products with an established customer base in southwest Colombia, has placed an initial purchase order and developed a marketing plan to generate strong sales. In addition to having stores in upscale malls and shopping centers they also sponsor a morning health talk radio show to discuss their featured products. The show targets an area of 350,000 people and attracts 25-35,000 listeners daily from 8-8:30 am. Salud Semillas' marketing plan for Sannabis products includes radio talk shows, telemarketing group, internet sales, newspaper ads, and a direct to customer health magazine called "Buena Vida" which is distributed directly to thousands of customer's homes monthly by Salud Semillas' trained personnel in strategic neighborhoods. For more information on Salud Semillas visit http://www.saludsemillas.com. Their radio show is also broadcast in Spain, France, and Germany as well as online. To listen to the show tune into http://emisora.univalle.edu.co.
Read the full New Colombia Resources (NEWC) press release at: http://www.financialnewsmedia.com/profiles/newc.html
"After 20 years of hard work developing high quality medical marijuana products in Colombia, I'm pleased that we were finally able to establish a mainstream market, our orders are coming in droves," said Juan Pablo Guzman, Director of Sannabis in Colombia. Dr. Robert Melamede Ph.D., scientific advisor to Sannabis and New Colombia Resources, is now in Dubai as a guest speaker at the World Congress on Oncology and Radiology held from April 18-20. He presented at the Novel Approaches to Cancer Therapeutics session. Dr. Melamede is a world renowned expert of the body's Endocannabinoid System and can easily educate world leaders on why cannabis cures and relieves. Dr. Melamede has firsthand knowledge of the effectiveness of Sannabis products in South America and is helping the company establish relationships and purchase orders with Middle Eastern countries. "The cannabis awakening is spreading across the world. The scientific knowledge of the unique healing powers of this plant are now known by more and more people around the world. The truth can no longer be suppressed by ignorance," stated Dr. Robert Melamede, Scientific Advisor to Sannabis and New Colombia Resources.
"In anticipation of having an approved export license, our approach to the international market is simple. You know cannabis cures but you don't want the hurdles of growing marijuana. Our region has grown the best medical strain for generations, we can grow and manufacture the highest quality 100% organic cannabis products for you at the most competitive cost possible. Colombian entrepreneurs are creating a new industry for the legal international medical cannabis and industrial hemp products market and we're proud to be a part of it," commented John Campo President of New Colombia Resources Inc.
.
.
Related Quotes
.
NEWC
0.0115
CBIS
0.0195
CARA
8.22
+8.27%
New Colombia Resources, Inc.? Watchlist
0.0115
OTC MarketsTue, Apr 19, 2016 3:59 PM EDT
NEW COLOMBIA RESOURCES INC Financials
EDGAR Online Financials 4 mths ago
NEW COLOMBIA RESOURCES INC Files SEC form 10-Q, Quarterly Report
EDGAR Online 11 mths ago
More
.
In other Cannabis/Legal Marijuana developments: Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabis-based medicines, is proud to extend its congratulations to the State of Pennsylvania as the 24th state to legalize cannabis for medical purposes. On Sunday, April 17, 2016, the Governor of Pennsylvania signed into law Senate Bill 3, legalizing medical cannabis consumption. Pennsylvania represents the 24th state to pass such legislation. The U.S. is nearly halfway to full medical legalization. As more states legalize medical cannabis, research and clinical trials can become simpler and less expensive to initiate and maintain.
Cara Therapeutics (CARA) was mentioned in a recent article published by TheStreet.com as being one of three Marijuana-Related Stocks poised for strong growth. Cara Therapeutics develops chemical substances to treat various degrees of pain is Shelton, Conn. Cara is a clinical-stage biopharmaceutical company that develops and commercializes new drugs that alleviate pain by selectively targeting kappa opioid receptors, a human protein. While GW Pharmaceuticals (GWPH) - another company mentioned in the article poised for strong growth - primarily treats pain through purified cannabis extracts that bind primarily to cannabinoid receptors in the brain (CB1), Cara boasts a more diverse and bigger portfolio of compounds focused on targeting immune cells (CB2) and unique opioid analgesics. Source: TheStreet.com
Terra Tech Corp. (TRTC) recently announced that its subsidiary, Edible Garden, a retail seller of locally grown hydroponic produce, herbs, and floral products, has signed an exclusive license agreement with Nutrasorb LLC, a spin-off of Rutgers University, to grow and commercialize nutritionally-enhanced lettuce varieties. Under the terms of the agreement, Edible Garden has the right to grow and sell Green and Red Super Lettuce across the North American and European continents as well as Australia. The produce will be high in vitamins A & C, magnesium, iron and potassium contents. It will also have high levels of fiber and chlorogenic acid. These nutritionally-enhanced, proprietary Green and Red Lettuces were developed by scientists at Rutgers University following years of intensive research.
Cannabis Sativa Inc. (CBDS) announced back in late February that HI Brands International Inc., a wholly owned subsidiary of Cannabis Sativa Inc., has entered into a trademark and licensing agreement with Trike Candy LLC, an Oregon Limited Liability Company to brand hi chocolate bars for the Oregon recreational marijuana market. Trike Candy is licensed to process marijuana infused products in the State of Oregon for sale in the recreational marijuana market.
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at financialnewsmedia.com. Follow us on Facebook: facebook.com/financialnewsmedia and Twitter: twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated one thousand nine hundred dollars for news coverage of the current press release issued by New Colombia Resources, Inc. by the company. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
U.S. Phone: +1-(954)345-0611
URL: http://www.financialnewsmedia.com
Date : 04/20/2016 @ 8:30AM Expansion of Legalized Cannabis Continues at a Torrid Pace in the U.S. and Globally For Leading Markets Worldwide
Date : 04/20/2016 @ 8:30AM
Source : InvestorsHub NewsWire
Stock : Cannabis Science, Inc. (PL) (CBIS)
Quote : 0.0195 0.0 (0.00%) @ 7:43AM
Expansion of Legalized Cannabis Continues at a Torrid Pace in the U.S. and Globally For Leading Markets Worldwide
Expansion of Legalized Cannabis Continues at a Torrid Pace in the U.S. and Globally For Leading Markets Worldwide; Company Receives Purchase Order for Medical Marijuana Products
Coral Springs, FL -- April 20, 2016 -- InvestorsHub NewsWire -- Global opportunities are promising for legalized marijuana and cannabis sector as revenues continue to thrive behind increased federal & governmental research and development of latest products. Marijuana & Cannabis Companies with current operations and developments of importance in the markets today are New Colombia Resources, Inc. (OTC: NEWC), Cannabis Science, Inc. (OTC: CBIS), Cara Therapeutics (NASDAQ: CARA), Terra Tech Corp. (OTC: TRTC) and Cannabis Sativa Inc. (OTCBB: CBDS).
New Colombia Resources, Inc. (OTC: NEWC), a U.S. company with natural resource assets in Colombia, is pleased to announce that its subsidiary, Sannabis SAS, has received orders from an established pharmacy chain distributing natural products in southwest Colombia. Natural Pharmacy chain Salud Semillas, a leading distributor of natural products with an established customer base in southwest Colombia, has placed an initial purchase order and developed a marketing plan to generate strong sales. In addition to having stores in upscale malls and shopping centers they also sponsor a morning health talk radio show to discuss their featured products. The show targets an area of 350,000 people and attracts 25-35,000 listeners daily from 8-8:30 am. Salud Semillas marketing plan for Sannabis products includes radio talk shows, telemarketing group, internet sales, newspaper ads, and a direct to customer health magazine called Buena Vida which is distributed directly to thousands of customers homes monthly by Salud Semillas trained personnel in strategic neighborhoods. For more information on Salud Semillas visit www.saludsemillas.com. Their radio show is also broadcast in Spain, France, and Germany as well as online. To listen to the show tune into http://emisora.univalle.edu.co.
Read the full New Colombia Resources (NEWC) press release at: http://www.financialnewsmedia.com/profiles/newc.html
After 20 years of hard work developing high quality medical marijuana products in Colombia, Im pleased that we were finally able to establish a mainstream market, our orders are coming in droves, said Juan Pablo Guzman, Director of Sannabis in Colombia. Dr. Robert Melamede Ph.D., scientific advisor to Sannabis and New Colombia Resources, is now in Dubai as a guest speaker at the World Congress on Oncology and Radiology held from April 18-20. He presented at the Novel Approaches to Cancer Therapeutics session. Dr. Melamede is a world renowned expert of the bodys Endocannabinoid System and can easily educate world leaders on why cannabis cures and relieves. Dr. Melamede has firsthand knowledge of the effectiveness of Sannabis products in South America and is helping the company establish relationships and purchase orders with Middle Eastern countries. The cannabis awakening is spreading across the world. The scientific knowledge of the unique healing powers of this plant are now known by more and more people around the world. The truth can no longer be suppressed by ignorance, stated Dr. Robert Melamede, Scientific Advisor to Sannabis and New Colombia Resources.
In anticipation of having an approved export license, our approach to the international market is simple. You know cannabis cures but you dont want the hurdles of growing marijuana. Our region has grown the best medical strain for generations, we can grow and manufacture the highest quality 100% organic cannabis products for you at the most competitive cost possible. Colombian entrepreneurs are creating a new industry for the legal international medical cannabis and industrial hemp products market and were proud to be a part of it, commented John Campo President of New Colombia Resources Inc.
In other Cannabis/Legal Marijuana developments: Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is proud to extend its congratulations to the State of Pennsylvania as the 24th state to legalize cannabis for medical purposes. On Sunday, April 17, 2016, the Governor of Pennsylvania signed into law Senate Bill 3, legalizing medical cannabis consumption. Pennsylvania represents the 24th state to pass such legislation. The U.S. is nearly halfway to full medical legalization. As more states legalize medical cannabis, research and clinical trials can become simpler and less expensive to initiate and maintain.
Cara Therapeutics (NASDAQ: CARA) was mentioned in a recent article published by TheStreet.com as being one of three Marijuana-Related Stocks poised for strong growth. Cara Therapeutics develops chemical substances to treat various degrees of pain is Shelton, Conn. Cara is a clinical-stage biopharmaceutical company that develops and commercializes new drugs that alleviate pain by selectively targeting kappa opioid receptors, a human protein. While GW Pharmaceuticals (NASDAQ: GWPH) - another company mentioned in the article poised for strong growth - primarily treats pain through purified cannabis extracts that bind primarily to cannabinoid receptors in the brain (CB1), Cara boasts a more diverse and bigger portfolio of compounds focused on targeting immune cells (CB2) and unique opioid analgesics. Source: TheStreet.com
Terra Tech Corp. (OTC: TRTC) recently announced that its subsidiary, Edible Garden, a retail seller of locally grown hydroponic produce, herbs, and floral products, has signed an exclusive license agreement with Nutrasorb LLC, a spin-off of Rutgers University, to grow and commercialize nutritionally-enhanced lettuce varieties. Under the terms of the agreement, Edible Garden has the right to grow and sell Green and Red Super Lettuce across the North American and European continents as well as Australia. The produce will be high in vitamins A & C, magnesium, iron and potassium contents. It will also have high levels of fiber and chlorogenic acid. These nutritionally-enhanced, proprietary Green and Red Lettuces were developed by scientists at Rutgers University following years of intensive research.
Cannabis Sativa Inc. (OTCBB: CBDS) announced back in late February that HI Brands International Inc., a wholly owned subsidiary of Cannabis Sativa Inc., has entered into a trademark and licensing agreement with Trike Candy LLC, an Oregon Limited Liability Company to brand hi chocolate bars for the Oregon recreational marijuana market. Trike Candy is licensed to process marijuana infused products in the State of Oregon for sale in the recreational marijuana market.
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at financialnewsmedia.com. Follow us on Facebook: facebook.com/financialnewsmedia and Twitter: twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated one thousand nine hundred dollars for news coverage of the current press release issued by New Colombia Resources, Inc. by the company. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
U.S. Phone: (954)345-0611
URL: www.financialnewsmedia.com
Source: FN Media Group
Los Angeles,PRWEB April 20, 2016 Cannabis Industry Coalition Launches My Health Freedom Social Justice Campaign
According to a 2015 Harris Poll, 81 percent of Americans support the legalization of cannabis for medicinal use. Despite this support, cannabis patients still suffer from societal stigma, in the forms of restricted access to job support, housing, and gun ownership, among other indignities. The time for that to end is now as California celebrates 20 years of medical cannabis under the Compassionate Use Act.
To support the goal of changing perception for cannabis users, California Cannabis Advocates (CCA), in partnership with Cult Creative, Unconventional Foundation 4 Autism, and elevate LA, today announced their patient awareness and education campaign: My Health Freedom. This is intended as a social justice "drop-in" campaign, encouraging patients to reframe their cannabis use and stand up as a Cannabis Patient or Cannabis Ally.
"I was immediately on-board with this effort--to be able to share my story in a way that supports the goal of the larger community, to help me feel more normalized in my life and my community," said Mama Sailene of Snoop Dogg's MerryJane.com Smoke In the Kitchen,"cannalebrity" and campaign partner.
"I felt the same way," added Ms. Hester-Perez, special needs family cannabis advocate. "When I 'came out' in 2009, it was such a shock to the community I was invited onto talk shows--I want this medicine to be less shocking for families. It really works."
My Health Freedom aims to collect 1,000,000 images of patients and allies, holding events all over the State of California and the United States. Plans are already in place for MHF events in Illinois, New Jersey, New York, Maryland, and the District of Columbia.
The time for change is now, join the My Health Freedom Campaign HERE or on Instagram @cannabis_patients. Companies interested in partnering on this project can contact the campaign.
The My Health Freedom Campaign is supported by a coalition of social entrepreneurs and activists who include:
Mieko Hester-Perez is a board member for NORML's Women's Alliance and Cannabis Science, Inc. as well as the mother of a child with severe autism. She has been featured across international media for her advocacy of pediatric cannabis use for autism, including appearances on Good Morning America, The Doctors Show, The Dr. Juan Rivera Show, ABC 20/20, and more. She now acts as a resource for parents seeking cannabis medicine for their children. Her new APP, The Joey Network, helps connect special needs families to cannabis services. It is available on iTunes and the Google Play store.
Felicia Carbajal (co-founder of California Cannabis Advocates) is a long-time cannabis patient, activist, educator, patient advocate, and community organizer. In 2013 she was honored by being named one of The Advocate Magazine 40 under 40 LGBT Leaders for her work in cannabis. California Cannabis Advocates is an educational and advocacy firm bringing cannabis dialog to patient and corporate environments outside the cannabis community.
Cult Creative is a full service marketing agency focusing on Instagram branding and promotion for the cannabis industry. elevate LA is the combined effort of a small group of social entrepreneurs striving to make Los Angeles stand out as a world-class cannabis destination.
Read the full story at http://www.prweb.com/releases/2016/04/prweb13355796.htm
© (c) 2016 PRWEB.COM Newswire
Cannabis Science Congratulates and Welcomes the State of Pennsylvania as the 24th State to Legalize Medical Cannabis
COLORADO SPRINGS, CO -- (Marketwired) -- 04/18/16 -- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is proud to extend its congratulations to the State of Pennsylvania as the 24th state to legalize cannabis for medical purposes.
On Sunday, April 17, 2016, the Governor of Pennsylvania signed into law Senate Bill 3, legalizing medical cannabis consumption. Pennsylvania represents the 24th state to pass such legislation. The U.S. is nearly halfway to full medical legalization. As more states legalize medical cannabis, research and clinical trials can become simpler and less expensive to initiate and maintain.
"While we don't currently have operations in Pennsylvania, we are certainly expecting a few calls to come in. We are excited to have the option to explore potential partnerships and research opportunities there in the future," said Director, President, CEO & Co-Founder, Raymond C. Dabney. "On behalf of our company and the medical cannabis industry as a whole, we would like to extend a warm welcome to the new patients that the SB3 bill will benefit."
The bill received 149 votes in favor and 46 votes opposing legalizing medical cannabis in a Republican-controlled House. The landslide victory on this bill shows even many of the more conservative politicians are opening their minds to the potential lifesaving properties of cannabis as another viable medical treatment.
Related links:
https://www.governor.pa.gov/governor-wolf-signs-medical-marijuana-legalization-bill-into-law/
About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
Forward-Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward-looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward- looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company are detailed from time to time in the company's reports filed with the Securities and Exchange Commission.
Cannabis Science, Inc.
Investor Relations
Teresa Misenheimer
teresa@cannabisscience.com
Tel: 1-888-263-0832
Cannabis Science, Inc.
Mr. Raymond C. Dabney
President & CEO, Co-Founder
raymond.dabney@cannabisscience.com
Tel:1-888-263-0832
Cannabis Science, Inc.
Mr. Robert Kane
Director & CFO
info@cannabisscience.com
Tel: 1-888-263-0832
Source: Cannabis Science, Inc.
Trottel.....very fine News and a nice green...CBIS...